FDA does not approve new drug application for troriluzole for spinocerebellar ataxias
In September 2024 Biohaven announced positive results from their study of troriluzole to treat SCA 1, 2, 3, 6, 7, 8 and 10. Following these results they submitted a new […]
FDA does not approve new drug application for troriluzole for spinocerebellar ataxias Read More »